Journal article · 2023 · Open access

VEGFR-3 Stimulation on LECs Boosts Type 2 Immunity After Vaccination

Trevin Robert Kurtanich, Jorge Emiliano Gomez Medellin, Melody A. Swartz

The Journal of Immunology, 210(Supplement_1), 79.18 · Published 1 May 2023 · DOI 10.4049/jimmunol.210.supp.79.18

Open PDFView at the publisherCite this paper

In brief

“VEGFR-3 Stimulation on LECs Boosts Type 2 Immunity After Vaccination” is a 2023 journal article by Trevin Robert Kurtanich and 2 co-authors, published in The Journal of Immunology. OpenAlex counts 0 citations as of 18 November 2026. It is open access: the full text is free to read at The Journal of Immunology.

Citations
0
Authors
3

Abstract

Lymphatic vessels are the main transport routes for fluid, antigens, exosomes, and immune cells from peripheral tissues to the lymph nodes (LNs). In addition to being pervasive through tissue, lymphatic vessels are also abundant within the LN, where they route lymph and cells around the B cell follicles and throughout the paracortical zone; thus, lymphatic endothelial cells (LECs) have unique access to lymph-borne molecules and interactions with immune cells. Upon acute inflammation or vaccination, LN LECs undergo expansion along with lymphocyte proliferation, a process dependent on the VEGF-C/VEGFR-3 signaling axis; however, it is not well understood how LN lymphatics and their expansion contribute to acute adaptive immune responses. Here, we asked how altering VEGFR-3 signaling LN LECs alters the adaptive immune response, using OVA + CpG (a TLR9 agonist) as a model for vaccination. We found that delivering VEGF-C156S, a VEGFR-3 specific agonist, multiple times prior to and concurrent with the inflammatory stimulus led to increased Th2 responses in terms of higher plasma levels of OVA-specific IgG1, more IgG1+ germinal center B cells, and increased production of Th2 cytokines (IL-4, IL-5, and IL-13) by CD4+ T cells upon restimulation. In loss-of-function experiments using a tamoxifen-inducible LEC-specific deletion of VEGFR-3, vaccination led to reduced plasma levels of OVA-specific IgG1 compared to tamoxifen-treated control littermates. Together, these findings suggest that in response to vaccination, VEGFR-3 signaling in LN LECs bias adaptive immune responses towards type 2 immunity. This highlights the role of lymphatics not just as passive conduits for fluid transport, but as having direct immunomodulatory function.

Cite this paper

Formatted from the catalogue record. Check names, capitals and page numbers against the paper before you submit.

APA 7

Kurtanich, T. R., Medellin, J. E. G., & Swartz, M. A. (2023). VEGFR-3 Stimulation on LECs Boosts Type 2 Immunity After Vaccination. The Journal of Immunology, 210(Supplement_1), 79.18. https://doi.org/10.4049/jimmunol.210.supp.79.18

MLA 9

Kurtanich, Trevin Robert, et al. “VEGFR-3 Stimulation on LECs Boosts Type 2 Immunity After Vaccination.” The Journal of Immunology, vol. 210, no. Supplement_1, 2023, p. 79.18. https://doi.org/10.4049/jimmunol.210.supp.79.18.

Chicago

Kurtanich, Trevin Robert, Jorge Emiliano Gomez Medellin, and Melody A. Swartz. 2023. “VEGFR-3 Stimulation on LECs Boosts Type 2 Immunity After Vaccination.” The Journal of Immunology 210 (Supplement_1): 79.18. https://doi.org/10.4049/jimmunol.210.supp.79.18.

Harvard

Kurtanich, T. R., Medellin, J. E. G. and Swartz, M. A. (2023) ‘VEGFR-3 Stimulation on LECs Boosts Type 2 Immunity After Vaccination’, The Journal of Immunology, 210(Supplement_1), p. 79.18. doi:10.4049/jimmunol.210.supp.79.18.

IEEE

T. R. Kurtanich, J. E. G. Medellin, and M. A. Swartz, “VEGFR-3 Stimulation on LECs Boosts Type 2 Immunity After Vaccination,” The Journal of Immunology, vol. 210, no. Supplement_1, p. 79.18, 2023, doi: 10.4049/jimmunol.210.supp.79.18.

BibTeX

@article{kurtanich2023vegfr,
  title     = {{VEGFR-3 Stimulation on LECs Boosts Type 2 Immunity After Vaccination}},
  author    = {Kurtanich, Trevin Robert and Medellin, Jorge Emiliano Gomez and Swartz, Melody A.},
  journal   = {The Journal of Immunology},
  year      = {2023},
  volume    = {210},
  number    = {Supplement_1},
  pages     = {79.18},
  doi       = {10.4049/jimmunol.210.supp.79.18},
  url       = {https://doi.org/10.4049/jimmunol.210.supp.79.18}
}

Download for a reference manager: BibTeX (.bib) · RIS for Zotero, Mendeley and EndNote (.ris)

Topic and keywords

Health Sciences › Medicine › Oncology › Lymphatic System and Diseases

  • VEGFR-3
  • lymphatic endothelial cells
  • VEGF-C
  • Th2 immune response
  • vaccination
  • germinal center B cells
  • IgG1
  • IL-4

Work with this paper

Most-cited papers in Medicine

All highly cited Medicine papers

Questions about this paper

How do I cite this paper in APA style?

Kurtanich, T. R., Medellin, J. E. G., & Swartz, M. A. (2023). VEGFR-3 Stimulation on LECs Boosts Type 2 Immunity After Vaccination. The Journal of Immunology, 210(Supplement_1), 79.18. https://doi.org/10.4049/jimmunol.210.supp.79.18

How many times has this paper been cited?

0 times, according to OpenAlex on 18 November 2026. Google Scholar and Scopus count different sets of sources, so their numbers differ.

Is this paper free to read?

Yes. It is open access at The Journal of Immunology: sign in and open the PDF from this page.

Who wrote this paper?

Trevin Robert Kurtanich, Jorge Emiliano Gomez Medellin, Melody A. Swartz.

What is the DOI of this paper?

10.4049/jimmunol.210.supp.79.18, permanently at https://doi.org/10.4049/jimmunol.210.supp.79.18. Sign in and open it from this page.

Bibliographic data from OpenAlex (CC0), last checked 18 November 2026. ResearchGuru does not host this paper; once you are signed in, the links open it at the publisher or the repository that does.